Ligand validation:5GLP

ARA: alpha-L-arabinopyranose

ARA is a Ligand Of Interest in 5GLP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5GLP_ARA_B_404	95%	66%	0.067	0.972	0.55	0.77	-	1	0	0	100%	1
5GLP_ARA_A_404	91%	74%	0.075	0.963	0.46	0.56	-	-	0	0	100%	1
5GLP_ARA_A_403	74%	59%	0.103	0.933	0.68	0.9	-	1	0	0	100%	1
5GLP_ARA_B_403	67%	61%	0.124	0.931	0.7	0.78	-	-	0	0	100%	1
5GLR_ARA_A_403	94%	62%	0.078	0.977	0.54	0.9	-	-	0	0	100%	0.5
5GLO_ARA_B_404	89%	63%	0.077	0.956	0.56	0.85	-	-	0	0	100%	1
2ARC_ARA_B_171	99%	80%	0.047	0.986	0.47	0.37	-	-	0	0	100%	1
5DEQ_ARA_A_301	98%	70%	0.052	0.976	0.5	0.65	-	-	0	0	100%	1
5LA0_ARA_A_606	98%	59%	0.062	0.983	0.61	0.95	-	-	0	0	100%	1
3A22_ARA_A_701	97%	60%	0.063	0.978	0.68	0.86	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.